{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:07:39Z","timestamp":1791068859903,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":291,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"HHS | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL132821"],"award-info":[{"award-number":["HL132821"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI125357"],"award-info":[{"award-number":["AI125357"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI 111475"],"award-info":[{"award-number":["AI 111475"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005640","name":"Flight Attendant Medical Research Institute, Inc.","doi-asserted-by":"publisher","award":["Clinical Innovator Award Program (FAMRI CIA 160010)"],"award-info":[{"award-number":["Clinical Innovator Award Program (FAMRI CIA 160010)"]}],"id":[{"id":"10.13039\/100005640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/colorado+bioscience+discovery+evaluation+grant+program","name":"State of Colorado, Colorado Bioscience Discovery Evaluation Grant Program","doi-asserted-by":"publisher","award":["CBDEG-2012"],"award-info":[{"award-number":["CBDEG-2012"]}],"id":[{"id":"10.13039\/colorado+bioscience+discovery+evaluation+grant+program","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM118819"],"award-info":[{"award-number":["GM118819"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1074\/jbc.ra119.012053","type":"journal-article","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T04:45:16Z","timestamp":1577508316000},"page":"1704-1715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models"],"prefix":"10.1016","volume":"295","author":[{"given":"Mari","family":"Numata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Tipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Trombley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoji","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pitchaimani","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Wei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"Harrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Voelker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.RA119.012053_bib1","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1056\/NEJMoa0903812","article-title":"Triple-reassortant swine influenza A (H1) in humans in the United States, 2005\u20132009","volume":"360","author":"Shinde","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.012053_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.1176225","article-title":"Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans","volume":"325","author":"Garten","year":"2009","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.012053_bib3","first-page":"123","article-title":"Update: Influenza activity\u2013United States, October 2, 2011\u2013February 11, 2012","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"10.1074\/jbc.RA119.012053_bib4","first-page":"483","article-title":"Influenza activity\u2013United States, 2013\u201314 season and composition of the 2014\u201315 influenza vaccines","volume":"63","author":"Epperson","year":"2014","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"10.1074\/jbc.RA119.012053_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.15585\/mmwr.mm6806a1","article-title":"Update: Influenza activity\u2013United States, September 30, 2018-February 2, 2019","volume":"68","author":"Blanton","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"10.1074\/jbc.RA119.012053_bib6","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.15585\/mmwr.mm6749a4","article-title":"Influenza activity\u2013United States, September 30\u2013December 1, 2018","volume":"67","author":"Budd","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep"},{"key":"10.1074\/jbc.RA119.012053_bib7","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA119.012053_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp068030","article-title":"Antiviral resistance in influenza viruses\u2013implications for management and pandemic response","volume":"354","author":"Hayden","year":"2006","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.012053_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.012053_bib10","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jama.2009.324","article-title":"The evolution of influenza resistance and treatment","volume":"301","author":"Weinstock","year":"2009","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA119.012053_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.2009.297","article-title":"Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenzae A (H1N1) virus","volume":"301","author":"Gooskens","year":"2009","journal-title":"JAMA"},{"key":"10.1074\/jbc.RA119.012053_bib12","doi-asserted-by":"crossref","first-page":"e01818","DOI":"10.1128\/JVI.01825-18","article-title":"In vitroin vivo characterization of novel neuraminidase substitutions in influenza A(H1N1)pdm09 identified using laninamivir-mediated in vitro selection","volume":"93","author":"Lloren","year":"2019","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.012053_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nri1528","article-title":"Immunoregulatory functions of surfactant proteins","volume":"5","author":"Wright","year":"2005","journal-title":"Nat. Rev. Immunol"},{"key":"10.1074\/jbc.RA119.012053_bib14","series-title":"Pulmonary Surfactant. Innate Immunity and Asthma","first-page":"145","article-title":"Asthma and Infections. In Lung Biology in Health and Disease","author":"Numata","year":"2010"},{"key":"10.1074\/jbc.RA119.012053_bib15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/jappl.2000.89.4.1283","article-title":"Altered airway surfactant phospholipid composition and reduced lung function in asthma","volume":"89","author":"Wright","year":"2000","journal-title":"J. Appl. Physiol"},{"key":"10.1074\/jbc.RA119.012053_bib16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1073\/pnas.0909361107","article-title":"Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection","volume":"107","author":"Numata","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.RA119.012053_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1194\/jlr.M055723","article-title":"Phosphatidylinositol inhibits respiratory syncytial virus infection","volume":"56","author":"Numata","year":"2015","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.012053_bib18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1194\/jlr.M037077","article-title":"Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection","volume":"54","author":"Numata","year":"2013","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.012053_bib19","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1165\/rcmb.2011-0194OC","article-title":"Phosphatidylglycerol suppresses influenza A virus infection","volume":"46","author":"Numata","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol"},{"key":"10.1074\/jbc.RA119.012053_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00003088-199426030-00005","article-title":"The fate of exogenous surfactant in neonates with respiratory distress syndrome","volume":"26","author":"Hallman","year":"1994","journal-title":"Clin. Pharmacokinet"},{"key":"10.1074\/jbc.RA119.012053_bib21","doi-asserted-by":"crossref","first-page":"e33118","DOI":"10.1371\/journal.pone.0033118","article-title":"Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret","volume":"7","author":"Koster","year":"2012","journal-title":"PLoS One"},{"key":"10.1074\/jbc.RA119.012053_bib22","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3201\/eid2406.172114","article-title":"Ferrets as models for influenza virus transmission studies and pandemic risk assessments","volume":"24","author":"Belser","year":"2018","journal-title":"Emerg. Infect. Dis"},{"key":"10.1074\/jbc.RA119.012053_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1348-0421.1992.tb02045.x","article-title":"Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection","volume":"36","author":"Cimolai","year":"1992","journal-title":"Microbiol. Immunol"},{"key":"10.1074\/jbc.RA119.012053_bib24","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"key":"10.1074\/jbc.RA119.012053_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1586\/ers.12.21","article-title":"Anionic pulmonary surfactant lipid regulation of innate immunity","volume":"6","author":"Numata","year":"2012","journal-title":"Expert Rev. Respir. Med"},{"key":"10.1074\/jbc.RA119.012053_bib26","doi-asserted-by":"crossref","first-page":"25488","DOI":"10.1074\/jbc.M109.040832","article-title":"Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2","volume":"284","author":"Kuronuma","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012053_bib27","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1194\/jlr.M065201","article-title":"Structural analogs of pulmonary surfactant phosphatidylglycerol inhibit toll-like receptor 2 and 4 signaling","volume":"57","author":"Kandasamy","year":"2016","journal-title":"J. Lipid Res"},{"key":"10.1074\/jbc.RA119.012053_bib28","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1074\/jbc.M110.170241","article-title":"Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages","volume":"286","author":"Kandasamy","year":"2011","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.RA119.012053_bib29","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.174.2.1091","article-title":"Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein","volume":"174","author":"Mueller","year":"2005","journal-title":"J. Immunol"},{"key":"10.1074\/jbc.RA119.012053_bib30","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMra1000449","article-title":"Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection","volume":"362","author":"Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.012053_bib31","doi-asserted-by":"crossref","first-page":"RRN1121","DOI":"10.1371\/currents.RRN1121","article-title":"Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact","volume":"1","author":"Deuffic-Burban","year":"2009","journal-title":"PLoS Curr"},{"key":"10.1074\/jbc.RA119.012053_bib32","doi-asserted-by":"crossref","first-page":"19463","DOI":"10.2807\/ese.15.02.19463-en","article-title":"Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July\u201315 November 2009","volume":"15","author":"Fuhrman","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1074\/jbc.RA119.012053_bib33","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1128\/JVI.01568-10","article-title":"The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells","volume":"85","author":"Zeng","year":"2011","journal-title":"J. Virol"},{"key":"10.1074\/jbc.RA119.012053_bib34","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/jbc.RA119.012053_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s40265-018-0899-1","article-title":"Baloxavir: first global approval","volume":"78","author":"Heo","year":"2018","journal-title":"Drugs"},{"key":"10.1074\/jbc.RA119.012053_bib36","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1128\/JVI.00188-14","article-title":"Enhanced viral replication and modulated innate immune responses in infant airway epithelium following H1N1 infection","volume":"88","author":"Clay","year":"2014","journal-title":"J. Virol"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817498681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925817498681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.RA119.012053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T21:34:57Z","timestamp":1654292097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925817498681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0021925817498681"],"URL":"https:\/\/doi.org\/10.1074\/jbc.ra119.012053","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary surfactant lipids inhibit infections with the pandemic H1N1 influenza virus in several animal models","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/jbc.RA119.012053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}]}}